Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 249

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 249
---
 BIOMATERIALS LTD.

NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 2: | SIGNIFICANT ACCOUNTING POLICIES (Cont.) |

| b. | Use of estimates in preparation of financial statements: |

The preparation of financial statements
in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets
and liabilities as of the dates of the financial statements and the reported amounts of expenses during the reporting period. Management
believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made.
Actual results could differ from those estimates.

| c. | Significant Accounting Policies: |

The significant accounting policies followed
in the preparation of these unaudited interim condensed financial statements are applied consistently with the significant accounting
policies applied in the Company’s latest annual financial statements as of and for the period ended December 31, 2023.

| d. | Basic and diluted loss per share: |

The loss and the weighted average number of shares used in
computing basic and diluted net loss per share is as follows:

| Numerator:                                                       |     | Six months ended 
 June 30,         
 2024             |           |   |     | 2023 |        |   |
|:-----------------------------------------------------------------|:----|:-----------------|----------:|:--|:----|:-----|-------:|:--|
| Net profit/(loss)                                                |     | $                |     7,207 |   |     | $    | (3,286 | ) |
| Interest accrued on convertible preferred                        
 shares                                                           |     |                  |       (23 | ) |     |      |    (23 | ) |
| Net profit/(loss) attributed to ordinary shares                  |     |                  |     7,184 |   |     |      | (3,309 | ) |
| Denominator:                                                     |     |                  |           |   |     |      |        |   |
| Number of ordinary shares                                        |     |                  |    64,879 |   |     |      | 64,879 |   |
| Number of convertible preferred shares                           |     |                  | 1,041,460 |   |     |      |      - |   |
|                                                                  |     |                  | 1,106,